BLACKSBURG, Va., Sept. 2 -- Virginia Polytechnic Institute and State University issued the following news release:
Researchers blocked a naturally occurring molecule to reverse pulmonary arterial hypertension in preclinical models, a finding that could point to a new treatment approach for people with a rare and often fatal lung disease.
Pulmonary arterial hypertension, or PAH, damages the blood vessels in the lungs and makes it harder for the heart to pump blood. It affects the heart's right ventricle that supplies oxygen rich blood to the lungs and, if left untreated, can lead to heart failure and death within two to three years after diagnosis.
In a study published inScience Translational Medicineand led by Yassine Sassi of the Fralin...